UK markets closed

Hyperfine, Inc. (HYPR)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.7900-0.0071 (-0.89%)
At close: 04:00PM EDT
0.7897 -0.00 (-0.04%)
After hours: 04:06PM EDT

Hyperfine, Inc.

351 New Whitfield Street
Guilford, CT 06437
United States
866 796 6767
https://hyperfine.io

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees131

Key executives

NameTitlePayExercisedYear born
Mr. R. Scott Huennekens CPA, M.B.A.Executive Chairman124.89kN/A1964
Ms. Maria SainzCEO, President & Director847kN/A1966
Dr. Jonathan M. Rothberg Ph.D.Founder & Vice Chairman50kN/A1964
Mr. Brett HaleChief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Corporate Secretary580.27kN/A1974
Dr. Thomas Teisseyre Ph.D.Chief Operating Officer519.24kN/A1984
Mr. Chip Truwit FACR, M.D.Vice President of Scientific AffairsN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

Corporate governance

Hyperfine, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.